A detailed history of Acadian Asset Management LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 1,879,933 shares of ACET stock, worth $1.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,879,933
Previous 1,085,093 73.25%
Holding current value
$1.8 Million
Previous $1.31 Million 106.25%
% of portfolio
0.01%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.07 - $1.63 $850,478 - $1.3 Million
794,840 Added 73.25%
1,879,933 $2.71 Million
Q2 2024

Aug 06, 2024

BUY
$1.21 - $2.4 $882,997 - $1.75 Million
729,750 Added 205.36%
1,085,093 $1.31 Million
Q1 2024

May 10, 2024

SELL
$1.76 - $3.45 $359,756 - $705,204
-204,407 Reduced 36.52%
355,343 $834,000
Q4 2023

Feb 13, 2024

BUY
$1.11 - $1.89 $40,782 - $69,440
36,741 Added 7.02%
559,750 $1.06 Million
Q3 2023

Nov 13, 2023

BUY
$1.37 - $3.4 $685,130 - $1.7 Million
500,095 Added 2182.49%
523,009 $715,000
Q2 2023

Aug 07, 2023

BUY
$2.13 - $7.13 $48,806 - $163,376
22,914 New
22,914 $54,000
Q3 2021

Nov 12, 2021

SELL
$6.29 - $9.93 $30,462 - $48,090
-4,843 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$9.19 - $15.93 $336,151 - $582,687
-36,578 Reduced 88.31%
4,843 $50,000
Q1 2021

May 11, 2021

SELL
$12.12 - $17.17 $42,541 - $60,266
-3,510 Reduced 7.81%
41,421 $542,000
Q4 2020

Feb 11, 2021

SELL
$10.36 - $14.77 $644,764 - $919,225
-62,236 Reduced 58.07%
44,931 $632,000
Q3 2020

Nov 09, 2020

BUY
$10.18 - $21.4 $1.09 Million - $2.29 Million
107,167 New
107,167 $1.27 Million

Others Institutions Holding ACET

About Adicet Bio, Inc.


  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $38.4M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.